Search
Enter keywords, a title or a report id number below.
Your Search for 'Schering-Plough: Pipeline - Products - Performance - Potential' returned 28 results - Page 1 of 2
Sort by
Sorted by
Rank
Top-Bottom
-
Merck & Co. Inc: PharmaVitae Profile
Datamonitor, Jun 2010 , Pages: 107company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually ... -
Innovative and Targeted Cancer Therapies: Key Technologies, New Applications and Leading Players
Scripp Business Insights, Jul 2007 , Pages: 128106 Schering-Plough 108 Eli Lilly 110 New market entry growth 111 Merck 112 Bayer Schering 113 Amgen 114 GlaxoSmithKline 115 Chapter 5 Key trends and implications 118 Summary 118 Introduction 119 ... -
Big Pharma's Key Lifecycle Management Strategies - Maximizing the Market Potential
GBI Research, Feb 2010 , Pages: 85identifying products that could fill portfolio gaps Big Pharma's Key Lifecycle Management Strategies: Maximizing the Market Potential “Big Pharma's Key Lifecycle Management Strategies: Maximizing the Market ... -
The Cancer Market Outlook to 2010
Scripp Business Insights, Nov 2005products R&D compounds Cancer portfolio sales forecasts Bristol-Myers Squibb Marketed products R&D compounds Cancer portfolio sales forecasts Schering-Plough Marketed products R&D compounds ... -
Key Trends in Offshoring Pharmaceutical R&D: Company Strategies, Emerging Markets and Impact on ROI
Scripp Business Insights, Mar 2009 , Pages: 13977 Amgen Inc 78 JVs and partnerships 79 Schering-Plough 79 R&D investment 80 Deals & acquisitions 80 Abbott Labs 81 Deals 82 Genentech 83 R&D investment 83 Acquisitions 84 Novo Nordisk A/S 85 Venture ... -
The Global Cancer Vaccine Market, 2nd Edition: Pipeline Analysis and Future Market Impact
Arrowhead Publishers, Jan 2011forecasts to 2020 to maximize your products commercial potential - Assess opportunities and risks influencing R&D in therapeutic cancer vaccines - Gain an impartial perspective of strategies that can be ... -
Agenix Limited (AGX) - Financial and Strategic SWOT Analysis Review
GlobalData, Mar 2013 , Pages: 37Leverage Ratios Efficiency Ratios List of Figures Agenix Limited, Pipeline Products by Therapy Area Agenix Limited, Pipeline Products by Development Phase Agenix Limited, Performance Chart (2008 ... -
The Asthma and COPD Market Outlook: Market Analysis of Future Growth and Leading Players by Sector
Scripp Business Insights, Jan 2005Ariflo Boehringer Ingelheim Therapeutic focus Anticholinergic market share Marketed products Schering-Plough Therapeutic focus Marketed products R&D pipeline AstraZeneca Therapeutic focus ... -
Dyslipidemia: Opportunities in Cardiovascular Risk Reduction
Biophoenix Limited, Jul 2008 , Pages: 210trials, biomarkers, surrogates of atherosclerosis for drug development, and over 150 products in commercial development. It also derives market forecasts (2008-2012) and assesses market potential. Why buy ... -
The Medicines Company (MDCO) - Financial and Strategic SWOT Analysis Review
GlobalData, Mar 2013 , Pages: 41, Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013 Johnson & Johnson Schering-Plough HealthCare Products, Inc Iroko Pharmaceuticals, LLC Medicure Inc. AntiCancer, Inc. BioChemics, Inc. ImmunoBiosciences ... -
VIVUS, Inc. (VVUS) - Financial and Strategic SWOT Analysis Review
GlobalData, Sep 2011 , Pages: 45., Pipeline Products by Therapy Area VIVUS, Inc., Pipeline Products by Development Phase VIVUS, Inc., Performance Chart (2006 - 2010) VIVUS, Inc., Ratio Charts VIVUS, Inc., Pharmaceuticals & Healthcare ... -
Biotech 2010 Life Sciences: Adapting for Success
Burrill & Company, Mar 2010 , Pages: 400with Pfizer' s $68 billion acquisition of Wyeth, the merger of Merck and Schering Plough, and Roche' s acquisition of Genentech. Big pharmaceutical companies, at the edge of the patent cliff, were busy ... -
The Rheumatoid Arthritis Market - Competitive Landscape and Clinical Stage Analysis
Arrowhead Publishers, May 2009 , Pages: 125challenging times ahead, with a number of new products already reaching registration phases, led by Centocor/Schering-Plough’s Simponi and Celltech/UCB’s Cimzia. The Rheumatoid Arthritis Market: Competitive ... -
The Rheumatoid Arthritis Market: Competitive Landscape and Clinical Stage Analysis
Arrowhead Publishers, May 2009 , Pages: 125times ahead, with a number of new products already reaching registration phases, led by Centocor/Schering-Plough’s Simponi and Celltech/UCB’s Cimzia. The Rheumatoid Arthritis Market: Competitive ... -
Pharmaceuticals - Global Outlook
Global Industry Analysts, Inc, Jan 2012 , Pages: 443therapeutic areas are expected to propel the global demand for Pharmaceuticals in the following years. Although considered largely recession-proof, as apparent by the performance of the pharmaceutical market ... -
Inhibitex, Inc. (INHX) - Financial and Strategic Analysis Review
GlobalData, Jul 2010 , Pages: 27products for the treatment of serious infectious diseases. The pipeline portfolio of the company includes FV-100, a powerful antiviral used for the treatment of herpes zoster and Aurexis, an improved ... -
Follow-On Products as a Defense Against Generics
Decision Resources, Inc, Dec 2005 , Pages: 17: - Schering-Plough - Bristol-Myers Squibb - Eli Lilly - AstraZeneca - Merck Sharp - Sepracor - Prilosec - Nexium - Forest Laboratories - Novartis - Pfizer - GlaxoSmithKline - Dieckmann ... -
Veterinary Health Markets
TriMark Publications, Jan 2012 , Pages: 4016.2.5 Global Veterinary Market by Species 6.2.6 Top Players in Animal Health 6.2.6.1 Pfizer's Animal Health Market Share by Species 6.2.6.2 Intervet Schering Plough's (ISP) Animal Health Market by ... -
Scrip R&D Databook 2006
Informa Healthcare, Jan 2006 , Pages: 427investment potential - Predict how long it will take your product to reach the market - Compare therapeutic products across companies - Get ahead of R&D trends, instead of spending time and resources in ... -
Animal Pharms Top 20: 2006 Edition
Informa Healthcare, Jan 2006 , Pages: 283the sector. Invest in this report to keep informed of the performance of your potential competitors, collaborators or customers. Key Findings: - Global sales of animal health and nutrition products ...
All rights reserved. © Copyright 2013 Research and Markets WWW4
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
